Appetite suppression and weight reduction by a centrally active aminosterol.
about
Metabolic Effects of CX3CR1 Deficiency in Diet-Induced Obese MiceThe cellular and molecular bases of leptin and ghrelin resistance in obesity.Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?Cellular bioenergetics as a target for obesity therapy.MSI-1436 reduces acute food intake without affecting dopamine transporter activity.Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia.Identification of squalamine in the plasma membrane of white blood cells in the sea lamprey, Petromyzon marinus.Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?Adiponectin acts in the brain to decrease body weight.Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor.Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice.Apparent receptor-mediated activation of Ca2+-dependent conductive Cl- transport by shark-derived polyaminosterols.Chronic overexpression of angiotensin-(1-7) in rats reduces cardiac reactivity to acute stress and dampens anxious behavior.Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress.Response to comment by Moxon et al.The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues.
P2860
Q27317248-CF1BF638-0DB6-43DB-9E1F-BC154C346928Q30235588-93059918-3142-4536-BE8C-8BDB6ACE3618Q33354067-9F057FB7-0D27-4DDC-B780-86C68B52A962Q33894407-00703359-083C-4C39-8DB4-B5016D0BB25FQ34155566-D9A524BE-E9A8-4528-9687-AF7B8932EE7BQ34235545-C99F3DB6-5D0C-4CBC-AF57-4E41C9C7BA7BQ34668091-734A69B6-77FE-43C6-A54B-553994C1DCDFQ37614594-6DD3AA68-D952-4A7E-8B1E-87C0EE142136Q38342591-BDF04DB1-F7E8-4274-89E0-1EDC6918843AQ42511192-2B572665-F346-474E-8A8E-71FF62C8AB72Q43193940-689FD909-C096-4E2A-9363-06C14CFD9010Q46658365-82AD8CD4-C04D-4BA6-BDD3-D8D5F4DACD55Q47335475-4B8E8EC6-2FBF-4CEC-8923-601AD2B4BE42Q47965638-07576DC5-944C-4FD1-9FE2-09A147F33B30Q49358806-35CACC51-5EC5-49A2-8C38-CDE5EE7877CFQ52729652-4C99AC32-BE61-46E6-9C1C-0D9D04FC286D
P2860
Appetite suppression and weight reduction by a centrally active aminosterol.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Appetite suppression and weight reduction by a centrally active aminosterol.
@en
Appetite suppression and weight reduction by a centrally active aminosterol.
@nl
type
label
Appetite suppression and weight reduction by a centrally active aminosterol.
@en
Appetite suppression and weight reduction by a centrally active aminosterol.
@nl
prefLabel
Appetite suppression and weight reduction by a centrally active aminosterol.
@en
Appetite suppression and weight reduction by a centrally active aminosterol.
@nl
P2093
P1433
P1476
Appetite suppression and weight reduction by a centrally active aminosterol
@en
P2093
Hiralben R Patel
Michael A Zasloff
Rexford S Ahima
Stanley M Hileman
P304
P356
10.2337/DIABETES.51.7.2099
P407
P577
2002-07-01T00:00:00Z